Financial Toxicity Among Single Mothers With Metastatic Breast Cancer
A study presented at the San Antonio Breast Cancer Symposium highlighted financial toxicity in underserved/underrepresented single mothers living with metastatic breast cancer, and how the situation can affect their physical, mental, and emotional health. In this exclusive MedPage Today video, Maryam Lustberg, MD, director of the Center for Breast Cancer at the Yale School of […]
FDA Flags Potential Guillain-Barre Risk With RSV Vaccine Candidates
Ahead of a 2-day meeting with FDA’s vaccine advisors, reviewers at the agency highlighted a rare but potential risk for Guillain-Barré syndrome with two vaccine candidates for respiratory syncytial virus (RSV). On Tuesday and Wednesday, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) will recommend whether the risk-benefit profile with Pfizer and GSK’s vaccine […]
Proposed User Instructions for OTC Narcan Has FDA Concerned
Ahead of an advisory committee meeting, FDA staff highlighted ongoing concerns about labeling for what could possibly be the first naloxone (Narcan) product approved for over-the-counter (OTC) use, labeling it “essential” in the emergency setting of an overdose. At a joint meeting of the Nonprescription Drug Advisory Committee and Anesthetic and Analgesic Drug Products Advisory […]
5 Happiest Types of Doctors
[embedded content] Over the last few years, the global pandemic has highlighted many of the long-standing issues within medicine. With all of this negativity, you might think that medicine is a dying career or that all physicians are burned out and miserable. Not so fast. There are still many physicians who lead happy and fulfilling […]
Year in Review: Lung Cancer
Lung cancer developments in 2021 were highlighted by the approval of an agent for a target once considered “undruggable,” the first approval of an adjuvant immunotherapy, broader screening recommendations from the U.S. Preventive Services Task Force (USPSTF), and more. First Approvals Targeting KRAS and a Rare EGFR Mutation In May, the FDA granted accelerated approval […]